Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 85.24

+0.5%

Feb 4 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2401)	6/16/2010 11:12:45 AM
From: Jibacoa	Read Replies (1) of 3722

PCYC is up 13% with volume about 1.31x its ADV bigcharts.marketwatch.com It announced today that it has entered into an agreements with various institutional investors for the sale of approximately 6,150,000 shares of its common stock in a registered direct offering at $6.51 per share, which was the closing price yesterday. Gross proceeds of the offering, before deducting expenses, are expected to be approximately $40M. PCYC plans to use the proceeds for general corporate purposes, including clinical trials, preclinical research expenses and other general expenses. The ACTAY is $10.60 Which seems doable if the market cooperates.<g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next